Business Jun 1, 2023
Contaminated drugs, shredded papers: U.S. FDA uncovers failures in India pharma factories
Authorities have suspended the licenses of more than a dozen unlisted drugmakers in the wake of dozens of cough syrup deaths.
Authorities have suspended the licenses of more than a dozen unlisted drugmakers in the wake of dozens of cough syrup deaths.
Singapore’s infections almost doubled in the final week of March to the highest rate this year, data from the Ministry of Health showed.
With Sri Lanka in the throes of its worst economic crisis since independence, India is re-engaging and attempting to tilt the balance in a strategic tussle with China.
In parts of the world where LGBTQ people face stigma and bias, patients are reluctant to seek testing or treatment for a disease that has recently afflicted gay and bisexual men.
It’s a vast project that shows how governments are growing increasingly concerned about China’s stranglehold over drug supplies — as well as the challenges they face in loosening it.
Even as boosters are likely to keep demand alive for COVID-19 inoculations worldwide, the desperate shortages that existed for much of last year have waned.
In early 2021, flare-ups in the Indian city of Amravati were the first visible warning that the delta variant was spreading. A devastating path across the world would soon follow.
As the Indian Council of Medical Research has acted as a key adviser to the government, it has drawn criticism from doctors and independent scientists.
The Serum Institute of India's travails have become a key illustration of how the effort to inoculate against COVID-19 has failed the developing world.
There is a growing realization that vaccine nationalism has the potential to ultimately prolong the pandemic.